RSPO2 and hepatocellular carcinoma: The genes amplified in this case were distinct from those reported in previous publications in HCC (MYC, RSPO2, CCND1, FGF19, VEGFA, CNND1, TERT),[15,16] since driver gene amplifications were not commonly seen in these reports.